Telehealth Reviews
Best GLP-1 Telehealth Programs for Women in 2026: 7 Real Options Compared
There is no single "best" GLP-1 program — there's a best program for your budget and risk tolerance. The core 2026 divide is branded medication (FDA-approved, pricier, legally settled) versus compounded (cheaper, not FDA-approved, and in a shrinking legal gray zone). We compared seven real programs on medication type, clinical oversight and pricing model — including the caveats their own landing pages skip.
How we compared (methodology)
Programs were assessed on: medication type (branded vs compounded), what the advertised price includes, visible clinical oversight (intake depth, prescriber interaction, dose management), and marketing honesty measured against the trial data (STEP 1: 14.9% average at 68 weeks; SURMOUNT-1: up to 20.9% at 72 weeks). We have an affiliate relationship with one program on this list (RxFemale), disclosed above and marked below; it did not buy its placement, and its entry carries the bluntest caution on the page.
| Program | Medication | Best for | Main caveat |
|---|---|---|---|
| Ro | Branded | Overall branded pathway + insurance help | Branded cash prices are real money |
| Hers | Branded / oral kits | Women-focused platform breadth | Oral kits are not GLP-1s — check what you're buying |
| Noom Med | Branded | Medication + behavior-change combo | App-heavy; subscription stacks |
| Found | Branded | Insurance navigation | Coverage still isn't guaranteed |
| LifeMD | Branded | Ongoing clinician access | Medication costs on top of membership |
| WeightWatchers Clinic | Branded | Structured program + community | Program layer isn't for everyone |
| RxFemale* | Compounded | Lowest advertised price | Compounded = not FDA-approved + real supply risk (see below) |
*Affiliate partner — see disclosure at the top of this page.
The branded pathway (Ro, Hers, Noom Med, Found, LifeMD, WeightWatchers Clinic)
These six differ mainly in wrapper, not medication: all prescribe FDA-approved branded GLP-1s (Wegovy, Zepbound and relatives), so the medication itself is the trial-tested product and the legal picture is settled. Choose between them on the service layer: Ro for a clean end-to-end branded experience, Hers if you want a women's-health platform around it (read carefully which of its weight products are actually GLP-1s), Noom Med if you want the behavioral program integrated, Found if insurance navigation is the blocker, LifeMD if you value an ongoing clinician relationship, and WeightWatchers Clinic if structure and community keep you consistent. Expect branded cash prices in the hundreds monthly; manufacturer direct-pay programs have narrowed the gap and any of these services can walk you through them.
The budget option: RxFemale (compounded) — read this part carefully
RxFemale is a women-focused telehealth program selling compounded semaglutide and tirzepatide from an advertised $129.99/month, with the prescription visit included and no insurance required. On advertised price it beats everything above, which is why it's on this list; the intake is online and the service is built specifically around women's weight loss.
Now the part its landing page won't tell you, and the reason it ranks as our budget pick rather than best overall: compounded GLP-1s are not FDA-approved products. The FDA has logged 990 adverse event reports for compounded semaglutide and more than 730 for compounded tirzepatide as of May 31, 2026 (many from dosing errors), warned 30 telehealth companies in March 2026 over marketing claims, and is moving to end large-scale compounding — so there is a genuine possibility that compounded supply disappears industry-wide with little notice. Its marketing also leans on "fast" framing the trials don't support (see the actual timelines). If the price difference is what makes treatment possible for you at all, it's a rational choice made with open eyes: go in with a continuity plan for switching to a branded option if supply stops.
Whichever you choose
A legitimate program screens your health history properly (including pregnancy plans), manages dose escalation, and quotes results that match the trials — not the ads. If an intake feels like a formality, that's your signal to go elsewhere.